Melinta Therapeutics to Host Meetings at the Morgan Stanley 16th Annual Global Healthcare Conference

World News: . []

NEW HAVEN, Conn., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, today announced that the company will be attending and hosting meetings at the Morgan Stanley 16 Annual Global Healthcare Conference.

Dan Wechsler, President and CEO of Melinta, and additional senior management will host meetings on Weds., Sept. 12, 2018. The conference will take place at the Grand Hyatt in New York, NY.

More news and information about Melinta Therapeutics

Published By:

Globe Newswire: 13:00 GMT Thursday 6th September 2018

Published: .

Search for other references to "melinta" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us